Efficacy News and Research

RSS

Adult stem cells can prevent Alzheimer's disease

In the first study of its kind, researchers at Korea's leading university and the RNL Bio Stem Cell Technology Institute announced this week the results of a study that suggests an astounding possibility: adult stem cells may not only have a positive effect on those suffering from Alzheimer's disease, they can prevent the disease.

27 Sep 2012

Enrollment complete in Resverlogix‘s RVX-208 Phase 2b trial on cardiovascular disease

Resverlogix Corp. today announced that it has completed enrollment in ASSURE, a Phase 2b clinical trial targeting high-risk cardiovascular disease patients.

27 Sep 2012

Pain survey effective for educating cancer patients

Surveying cancer patients on their knowledge about how to manage their pain is an effective way to target them for educational intervention, researchers say.

26 Sep 2012

NOXXON commences NOX-A12 Phase IIa trial in relapsed MM

NOXXON Pharma today announced the treatment of the first cohort of three multiple myeloma (MM) patients in a Phase IIa clinical trial of its anti-CXCL12/SDF-1 (CXC chemokine ligand 12 / Stromal Cell-Derived Factor-1) Spiegelmer NOX-A12.

26 Sep 2012

PsiOxus initiates ColoAd1 phase I/II trial in metastatic solid tumours

PsiOxus Therapeutics, Ltd. has treated the first patient in its phase I/II clinical trial of ColoAd1for the treatment of metastatic solid tumours.

26 Sep 2012

Daytime oxygen link to poor sleep in COPD

Patients with chronic obstructive pulmonary disease experience poorer sleep quality than those without the disease, say the authors of an Irish study.

25 Sep 2012

NeuroSigma to launch Monarch eTNS system at 10th European Congress on Epileptology

NeuroSigma, Inc., a Los Angeles-based medical device company, announced today that its Monarch eTNS system for the adjunctive treatment of epilepsy and depression will make its debut at the 10th European Congress on Epileptology, which takes place in London, England from September 30 to October 4, 2012.

25 Sep 2012

UH Rainbow pediatric sports medicine specialist strongly cautions against home trampolines: AAP

Susannah Briskin, MD, a pediatric sports medicine specialist with University Hospitals Rainbow Babies & Children's Hospital, is the co-author of an updated report from the American Academy of Pediatrics (AAP) strongly cautioning against home trampolines. The report provides updated data on the number of and types of injuries caused by trampolines.

25 Sep 2012

NanoBio to present data from preclinical studies at 8th Annual International RSV Symposium

NanoBio Corporation announced today it will present data from three preclinical studies at the 8th Annual International Respiratory Syncytial Virus (RSV) Symposium taking place from Sept. 27-30 in Santa Fe, N.M.

25 Sep 2012

New clinical trial to evaluate DEX-M74 against hereditary inclusion body myopathy

Researchers have launched a clinical trial to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). National Institutes of Health scientists from the National Center for Advancing Translational Sciences (NCATS) and the National Human Genome Research Institute (NHGRI) will conduct the clinical trial at the NIH Clinical Center.

25 Sep 2012

Lonafarnib proves effective for children with progeria

Results of the first-ever clinical drug trial for children with Progeria, a rare, fatal "rapid-aging" disease, demonstrate the efficacy of a farnesyltransferase inhibitor (FTI), a drug originally developed to treat cancer. The clinical trial results, completed only six years after scientists identified the cause of Progeria, included significant improvements in weight gain, bone structure and, most importantly, the cardiovascular system, according to The Progeria Research Foundation (PRF) and Boston Children's Hospital.

25 Sep 2012

pSivida reports revenues of $699,000 for fourth quarter 2012

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced financial results for its fourth quarter and fiscal year ended June 30, 2012.

25 Sep 2012

Concentrated high-protein liquid fortifier boosts ICU babies’ growth

Breast milk fortified with an ultraconcentrated high-protein liquid increases growth and is well-tolerated by preterm babies in comparison with a lower-protein enriched powder alternative, research shows.

24 Sep 2012

BG-12 effective for relapsing–remitting multiple sclerosis

Results of the CONFIRM and DEFINE studies suggest that dimethyl fumarate should be considered as an oral treatment for patients with relapsing–remitting multiple sclerosis.

24 Sep 2012

ESMO Designated Center of Integrated Oncology and Palliative Care accreditation for 16 new centers

The European Society for Medical Oncology has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centers. The centers will receive the acknowledgment at the ESMO 2012 Congress, in Vienna, Austria, 28 September - 2 October.

24 Sep 2012

Astellas seeks FDA approval for tacrolimus NDA for prophylaxis of organ rejection

Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration seeking approval for tacrolimus extended release capsules for the prophylaxis of organ rejection in adult kidney transplant recipients and adult male liver transplant recipients.

24 Sep 2012

Efficacy News and Research

Adult stem cells can prevent Alzheimer's disease

Enrollment complete in Resverlogix‘s RVX-208 Phase 2b trial on cardiovascular disease

Pain survey effective for educating cancer patients

NOXXON commences NOX-A12 Phase IIa trial in relapsed MM

PsiOxus initiates ColoAd1 phase I/II trial in metastatic solid tumours

Daytime oxygen link to poor sleep in COPD

NeuroSigma to launch Monarch eTNS system at 10th European Congress on Epileptology

UH Rainbow pediatric sports medicine specialist strongly cautions against home trampolines: AAP

NanoBio to present data from preclinical studies at 8th Annual International RSV Symposium

New clinical trial to evaluate DEX-M74 against hereditary inclusion body myopathy

Lonafarnib proves effective for children with progeria

pSivida reports revenues of $699,000 for fourth quarter 2012

Concentrated high-protein liquid fortifier boosts ICU babies’ growth

BG-12 effective for relapsing–remitting multiple sclerosis

ESMO Designated Center of Integrated Oncology and Palliative Care accreditation for 16 new centers

Astellas seeks FDA approval for tacrolimus NDA for prophylaxis of organ rejection

Ohr commences Phase II clinical trial of Squalamine for wet-AMD

NanoViricides’ oral FluCide dramatically improves survival in animals with H3N2 influenza A

Sleep medicine and research: an interview with James K. Walsh

Boehringer Ingelheim completes enrollment in nintedanib Phase III trials for IPF

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News